Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    michaelson
Show Display Options
Rank Status Study
1 Completed
Has Results
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: ET 743
2 Completed
Has Results
Study of SU11248 in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Sunitinib
3 Completed Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Condition: Cancer
Intervention:
4 Completed
Has Results
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Urothelial Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: Paclitaxel;   Biological: Trastuzumab;   Radiation: Radiation Therapy
5 Active, not recruiting Tivozanib + Enzalutamide in Adv Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Tivozanib;   Drug: Enzalutamide
6 Active, not recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
7 Withdrawn Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Sunitinib;   Drug: Bevacizumab
8 Completed
Has Results
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Neoplasm Metastases
Interventions: Drug: Gemcitabine;   Drug: Sunitinib

Indicates status has not been verified in more than two years